Condensed heterocyclic compound
US9975903B2 · kind B2 · utility
0Cited by
8References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 24, 2015 |
| Grant date | May 22, 2018 |
| Priority date | — |
| Expiry date | Dec 24, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/655
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect and is useful in the treatment or prevention of obesity, diabetes mellitus, or the like, and a medicament containing the same. Specifically, the present invention relates to a compound represented by the following formula (I) or a salt thereof, and a medicament containing the same [in the formula, each symbol is as defined in the specification].
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.